Highlights
MWC technical excellence helps NZ attract new medicines
A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.
read the full story
MWC continues to lead the way in NZ cancer vaccine research
Immune therapy is one of the most exciting and promising areas of cancer research. Around New Zealand, teams of Maurice Wilki...
read the full story
MWC senior leadership team welcomes new appointees
We highlight the recent appointments of three exceptional scientists – Associate Professor Rinki Murphy, Professor Debbie Hay...
read the full story
Cancer drug advances to phase II clinical trials
A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical tria...
read the full story
Partnerships boost business: MWC supports Auckland Clinical Studies (2013)
The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cem...
read the full story
New chemistry transforms cancer vaccine (2013)
A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours stud...
read the full story
Stepping up the fight: The Tuberculosis Flagship (2013)
The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to ...
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidat...
read the full story
A licence to manufacture medicines (2012)
A licence to manufacture medicines has been granted to a University of Auckland facility that will produce the active ingredi...
read the full story
Dissecting drug side effects offers hope (2011)
Researchers from the Maurice Wilkins Centre have discovered how a common class of medicines causes diabetes-like symptoms, an...
read the full story
Joining forces against infectious disease (2010)
The 2010 Superbugs Symposium convened by the Maurice Wilkins Centre brought together more than 350 medical professionals and ...
read the full story
Drug selection a milestone for spin-out (2010)
In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidat...
read the full story
Help with difficult diagnoses (2009)
Maurice Wilkins Centre technology is helping Auckland Hospital with difficult diagnoses.
read the full story
Creating connections between drug discovery and business (2009)
The Maurice Wilkins Centre hosted the New Zealand Drug Discovery Symposium in September 2009, bringing together more than 450...
read the full story
Cancer stealth drug enters clinical development (2010)
The first of an exciting new class of anticancer drugs will proceed to clinical development under an international deal annou...
read the full story
New Zealand patients trial local cancer drug (2012)
Cancer patients in Auckland, Waikato and the United States are participating in the first clinical trial of an exciting new d...
read the full story
New drug targets treatment-resistant cancer (2011)
A new drug targeting an important group of cancer cells attracted international funding in 2011 and will soon enter clinical ...
read the full story